| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UltraRapid Communication |
From the Department for Internal Medicine III (E.B.F., K.W., J.S.), University Hospital of the Saarland; and Department for Internal Medicine II (G.N., N.W.), University Hospital Bonn, Germany.
Correspondence to Prof Dr Georg Nickenig, Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany. E-mail georg.nickenig{at}ukb.uni-bonn.de
Our goal was to identify functionally important subpopulations within the heterogenous group of endothelial progenitor cells (EPC). Fluorescence-activated cell sorter analysis of CD133+ progenitor cells revealed the presence of CD34+ and CD34 subpopulations. CD34/133+ progenitors differentiate into CD34+/133+ EPC, adhere more potently than these in response to SDF-1, and rapidly home to sites of limb ischemia in human volunteers. In human coronary atherectomy samples, fewer CD34/133+ than CD34+/133+ EPC are present in stable plaques, whereas cell numbers increase with a reversion of the ratio in unstable lesions. In CD34/133+ EPC-injected nude mice, more transplanted cells coexpressing endothelial markers home to carotid artery lesion endothelium than in CD34+/133+-injected mice. In the former, lesions were smaller and reendothelialization higher than in the latter. We identified a new CD34/133+ EPC subpopulation, which is apparently a precursor of "classical" CD34+/133+ EPC, and functionally more potent than these with respect to homing and vascular repair.
Key Words: endothelial progenitor cells CD34/CD133 arterial injury reendothelialization atherosclerosis
This article has been cited by other articles:
![]() |
C. Nesselmann, W. Li, N. Ma, and G. Steinhoff Stem cell-mediated neovascularization in heart repair Therapeutic Advances in Cardiovascular Disease, February 1, 2010; 4(1): 27 - 42. [Abstract] [PDF] |
||||
![]() |
P. Ebner, F. Picard, J. Richter, E. Darrelmann, M. Schneider, B.-E. Strauer, and M. Brehm Accumulation of VEGFR-2+/CD133+ cells and decreased number and impaired functionality of CD34+/VEGFR-2+ cells in patients with SLE Rheumatology, January 1, 2010; 49(1): 63 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Boda, M. Udvardy, K. Razso, K. Farkas, J. Toth, L. Jambor, Z. Olah, P. Ilonczai, M. Szarvas, J. Kappelmayer, et al. Stem Cell Therapy: A Promising and Prospective Approach in the Treatment of Patients With Severe Buerger's Disease Clinical and Applied Thrombosis/Hemostasis, October 1, 2009; 15(5): 552 - 560. [Abstract] [PDF] |
||||
![]() |
W. Yao, A. L. Firth, R. S. Sacks, A. Ogawa, W. R. Auger, P. F. Fedullo, M. M. Madani, G. Y. Lin, N. Sakakibara, P. A. Thistlethwaite, et al. Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L870 - L878. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Chen, R. A.F. Dixon, L.-Y. Ke, and J. T. Willerson Vascular Progenitor Cells in Diabetes Mellitus: Roles of Wnt Signaling and Negatively Charged Low-Density Lipoprotein Circ. Res., May 8, 2009; 104(9): 1038 - 1040. [Full Text] [PDF] |
||||
![]() |
D. P Sieveking and M. K. Ng Cell therapies for therapeutic angiogenesis: back to the bench Vascular Medicine, May 1, 2009; 14(2): 153 - 166. [Abstract] [PDF] |
||||
![]() |
Y. Feng, M. van Eck, E. Van Craeyveld, F. Jacobs, V. Carlier, S. Van Linthout, M. Erdel, M. Tjwa, and B. De Geest Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer Blood, January 15, 2009; 113(3): 755 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Maeng, H.-J. Choi, J.-Y. Kwon, Y.-W. Park, K.-S. Choi, J.-K. Min, Y.-H. Kim, P.-G. Suh, K.-S. Kang, M.-H. Won, et al. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLC{beta}2 axis Blood, January 1, 2009; 113(1): 233 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gossl, U. I. Modder, E. J. Atkinson, A. Lerman, and S. Khosla Osteocalcin Expression by Circulating Endothelial Progenitor Cells in Patients With Coronary Atherosclerosis J. Am. Coll. Cardiol., October 14, 2008; 52(16): 1314 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Thomas, R. Redgrave, M. S. Cunnington, P. Avery, B. D. Keavney, and H. M. Arthur Circulating Endothelial Progenitor Cells Exhibit Diurnal Variation Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): e21 - e22. [Full Text] [PDF] |
||||
![]() |
E. Shantsila, T. Watson, H.-F. Tse, and G. Y.H. Lip New insights on endothelial progenitor cell subpopulations and their angiogenic properties. J. Am. Coll. Cardiol., February 12, 2008; 51(6): 669 - 671. [Full Text] [PDF] |
||||
![]() |
S. Voo, J. Eggermann, M. Dunaeva, C. Ramakers-van Oosterhoud, and J. Waltenberger Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction Eur. Heart J., January 2, 2008; 29(2): 241 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Wojakowski, M Kucia, M Kazmierski, M Z Ratajczak, and M Tendera Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart, January 1, 2008; 94(1): 27 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Irwin, K. Helm, N. Campbell, M. Imamura, K. Fagan, J. Harral, M. Carr, K. A. Young, D. Klemm, S. Gebb, et al. Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L941 - L951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Erbs, A. Linke, V. Schachinger, B. Assmus, H. Thiele, K.-W. Diederich, C. Hoffmann, S. Dimmeler, T. Tonn, R. Hambrecht, et al. Restoration of Microvascular Function in the Infarct-Related Artery by Intracoronary Transplantation of Bone Marrow Progenitor Cells in Patients With Acute Myocardial Infarction: The Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) Trial Circulation, July 24, 2007; 116(4): 366 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Timmermans, F. Van Hauwermeiren, M. De Smedt, R. Raedt, F. Plasschaert, M. L. De Buyzere, T. C. Gillebert, J. Plum, and B. Vandekerckhove Endothelial Outgrowth Cells Are Not Derived From CD133+ Cells or CD45+ Hematopoietic Precursors Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1572 - 1579. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Scheller, U. Speck, and M. Bohm Prevention of restenosis: is angioplasty the answer? Heart, May 1, 2007; 93(5): 539 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Fadini, C. Agostini, and A. Avogaro Endothelial progenitor cells and erectile dysfunction Eur. Heart J., March 1, 2007; 28(5): 639 - 640. [Full Text] [PDF] |
||||
![]() |
S. Witkowski and J. M. Hagberg Progenitor cells and age: can we fight aging with exercise? J Appl Physiol, March 1, 2007; 102(3): 834 - 835. [Full Text] [PDF] |
||||
![]() |
G. P. Fadini, S. Sartore, M. Albiero, I. Baesso, E. Murphy, M. Menegolo, F. Grego, S. Vigili de Kreutzenberg, A. Tiengo, C. Agostini, et al. Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2140 - 2146. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Fadini, A. Coracina, I. Baesso, C. Agostini, A. Tiengo, A. Avogaro, and S. Vigili de Kreutzenberg Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population Stroke, September 1, 2006; 37(9): 2277 - 2282. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |